We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Simple Noninvasive Test for Airway Inflammation

By HospiMedica staff writers
Posted on 29 May 2002
The pH of expired breach condensate represents a simple, noninvasive, inexpensive, and easily repeatable way to evaluate airway inflammation, according to a study reported by Greek researchers in the May 15, 2002, issue of the American Journal of Respiratory and Critical Care Medicine, a publication of the American Thoracic Society.

In the study, researchers studied 90 patients with airway diseases. More...
Of these, 40 had asthma, 20 with mild persistent asthma and 20 with moderate asthma. Of the remaining 50 patients, 20 had bronchiectases, 20 had chronic obstructive pulmonary disease (COPD), and 10 were control subjects. The findings of the researchers confirmed their initial hypothesis that airway acidification from within the body is strongly related to inflammation in these three diseases.

Patients with moderate asthma had significantly lower values than patients with the mild version or the control subjects. In patients with COPD and bronchiectases, the pH values were correlated with both sputum neutrophilia and oxidative stress. In patients with moderate asthma, a significant correlation was found between the pH and sputum eosinophilia total nitrate/nitrate and oxidative stress. When the inflammatory process is well controlled, the pH remains within normal limits. The study was conducted by researchers at the Army General Hospital, Athens, Greece.




Related Links:
American Thoracic Soc.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.